| Target Price | $402.90 |
| Price | $424.87 |
| Deviation | 5.17% |
| Number of Estimates | 29 |
| 29 Analysts have issued a price target Marriott 2027 . The average Marriott target price is $402.90. This is 5.17% lower than the current stock price. The highest price target is $450.45 6.02% , the lowest is $282.80 33.44% . | |
| A rating was issued by 32 analysts: 16 Analysts recommend Marriott to buy, 15 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Marriott stock has an average upside potential 2027 of 5.17% . Most analysts recommend the Marriott stock at Purchase. |
31 Analysts have issued a sales forecast Marriott 2026 . The average Marriott sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
31 Analysts have issued an Marriott EBITDA forecast 2026. The average Marriott EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
32 Marriott Analysts have issued a net profit forecast 2026. The average Marriott net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Oct 22 2026 |
| JP Morgan |
Neutral
➜
Neutral
|
Unchanged | Oct 21 2026 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Oct 19 2026 |
| Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Oct 19 2026 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Oct 16 2026 |
| Freedom Broker |
➜
Buy
|
Initiated | Oct 14 2026 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Oct 12 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Oct 22 2026 |
|
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
Oct 21 2026 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Oct 19 2026 |
|
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Oct 19 2026 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Oct 16 2026 |
|
Initiated
Freedom Broker:
➜
Buy
|
Oct 14 2026 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Oct 12 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


